Brian L. Robbins - Concepedia

Author

Brian L. Robbins

St. Jude Children's Research Hospital ORCID

Also Known As

B L Robbins, B Robbins, B. Robbins, B.L. Robbins, BL Robbins, Brian L Robbins, Brian L. Robbins, Brian Robbins, Thorpe, Edwin

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

St. Jude Children's Research Hospital University of Nebraska Medical Center University of Tennessee Health Science Center Frontier Science & Technology Research Foundation Northwestern University

About

Brian L. Robbins is an author at St. Jude Children's Research Hospital specializing in medicine, pharmacology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	725
2	Engineering	2	2	47
3	Health Sciences	2	2	59
4	Natural Sciences	2	2	121
5	Allergy	1	1	18

Brian L. Robbins

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Anti-Human Immunodeficiency Virus Activity and Cellular Metabolism of a Potential Prodrug of the Acyclic Nucleoside Phosphonate 9- <i>R</i> -(2-Phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA Brian L. Robbins, R V Srinivas, Choung Kim, Antimicrobial Agents and Chemotherapy	1998	319
The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards Tom Delahunty, Lane R. Bushman, Brian L. Robbins, Journal of Chromatography B MedicineImmunologyInternal StandardsSimultaneous AssayAntiviral Therapy	2009	109
Metabolic pathways for activation of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine in human lymphoid cells Brian L. Robbins, Jack Greenhaw, Michele Connelly, Antimicrobial Agents and Chemotherapy Cell DeathChemical BiologyHuman Lymphoid CellsOxidative StressPmea-resistant Subline	1995	106
Metabolism and in vitro antiretroviral activities of bis(pivaloyloxymethyl) prodrugs of acyclic nucleoside phosphonates R V Srinivas, Brian L. Robbins, Michele Connelly, Antimicrobial Agents and Chemotherapy	1993	106
Mechanism of uptake of the phosphonate analog (S)-1-(3-hydroxy-2-phosphonylmethoxy-propyl)cytosine (HPMPC) in vero cells Michele Connelly, Brian L. Robbins, Arnold Fridland Biochemical Pharmacology Signal TransductionBiochemistryMembrane TransportProtein PhosphorylationMedicine	1993	81
Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results Ellen G. Chadwick, Edmund V. Capparelli, Ram Yogev, AIDS	2008	76
Enzymatic assay for measurement of zidovudine triphosphate in peripheral blood mononuclear cells Brian L. Robbins, Jack Rodman, Cheryl McDonald, Antimicrobial Agents and Chemotherapy	1994	68
Systemic Pharmacokinetics and Cellular Pharmacology of Zidovudine in Human Immunodeficiency Virus Type 1–Infected Women and Newborn Infants John H. Rodman, Patricia M. Flynn, Brian L. Robbins, The Journal of Infectious Diseases Newborn InfantsPlasma ZidovudineNeurovirologyHuman RetrovirusPharmacology	1999	60
Pharmacokinetics and Safety of Single-Dose Tenofovir Disoproxil Fumarate and Emtricitabine in HIV-1-Infected Pregnant Women and Their Infants Patricia M. Flynn, Mark Mirochnick, David E. Shapiro, Antimicrobial Agents and Chemotherapy Maternal ImmunizationMg TdfTreatment And PreventionNeurovirologyPharmacology	2011	56
Early Initiation of Lopinavir/Ritonavir in Infants Less Than 6 Weeks of Age Ellen G. Chadwick, Jorge Pinto, Ram Yogev, The Pediatric Infectious Disease Journal	2009	54

Page 1